Corcept Therapeutics | CORT - Capital Social Ordinario

Precio De Mercado
41.69
Cambio Diario
0.84 2.06%
Mensual
22.65%
Anual
-40.86%
Q2 Expectativa
41.21




Capital Social Ordinario Cambio Fecha
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Assertio Holdings USD 9K 0 2023-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
J&J USD 2.41B 584K 2025-09
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Omeros USD 611K 17K 2023-12
Pacira USD 41.12M 1.85M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
TG Therapeutics USD 155.21M 2.81M 2025-09